ArticleInfectious diseases and therapy2025

An Economic Model to Assess the Cost Impact of Using Xpert Carba-R to Screen Carbapenemase-Producing Enterobacterales in Comparison with Standard of Care, in a National Health Service Setting.

Mondher Toumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.